Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Evaluate whether travel rewards or cash back cards are better for you. Find the card that maximizes your benefits.
26,293 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
Investors are expanding beyond Vanguard in March 2026 as cost, access, and tool diversity drive choice. This report h...
Valero Energy and Baker Hughes surge in 2026 on oil strength and refining margins, while First Solar pivots lower ami...
In a volatile economy, boards are adjusting performance targets to preserve executive compensation. This piece explai...
When a founder-led brand hits a leadership cliff, markets react fast. This article explains why holding's stock crash...
Nvidia’s quarterly print arrives amid an AI demand cycle that remains uneven. Analysts say nvidia earnings don’t matt...
Five-year losses on laddered bonds have stretched retirees' portfolios. If Kevin Warsh takes the helm, his policy cho...
Inflation surging is reordering the playbook for investors as political pressure over rate cuts intensifies. This art...
Iren is pursuing a bold AI infrastructure push with a $4.4 billion target. This article breaks down what that means f...
If you’re evaluating FLR, you’re weighing big projects, complex contracts, and a shifting risk profile. This guide br...
SpaceX is taking on massive debt to accelerate its AI ambitions. This in-depth analysis explains the financing move, ...